With over a century of operating history, a global distribution network reaching healthcare institutions in virtually every country, and consistent earnings growth, Becton Dickinson is a reliable blue chip in the medical technology space.
Becton Dickinson is a Dividend Aristocrat with over 50 consecutive years of annual dividend increases, supported by the non-discretionary nature of its medical supply products that generate stable cash flows in any economic environment.
Becton Dickinson supplies the syringes, needles, IV catheters, diagnostic systems, and medication management platforms that hospitals and clinics around the world depend on daily, making it an indispensable healthcare stock.
Data updated Feb 15 ยท Source: Twelve Data
Becton Dickinson is a global medical technology leader specializing in medical devices, instrument systems, and reagents. The company holds dominant positions in syringes, needles, and diagnostic systems, providing a durable competitive moat. At a P/E of 12.65 with EPS of $13.90, BDX appears attractively valued relative to healthcare peers, though this may reflect market concerns about growth trajectory.
The bull case centers on BD's essential product portfolio, recurring revenue streams, and recent strong momentum " up 29% over six months with the stock trading well above its 50-day moving average. The planned separation of its Biosciences segment could unlock shareholder value.
However, the bear case is notable: the stock is down nearly 10% over five years, significantly underperforming the broader market. Integration challenges from the Alaris infusion pump recall and elevated debt from acquisitions remain headwinds. The dividend yield, while supported by a 50+ year growth streak, is modest. BD offers defensive healthcare exposure but has struggled to deliver meaningful capital appreciation, making it better suited for income-oriented, conservative portfolios.
You are Claude Opus 4.6, an AI stock analyst for Dirvest.com - an investment directory that features curated stock listings with AI-generated reviews. Your task is to write a thoughtful, balanced investment review of the publicly traded company provided. Guidelines: - Write an investment-focused review based on what you know about this company and its stock - Assess the investment thesis: financial health, growth prospects, competitive position, and risks - If financial data is provided, reference key metrics (valuation, earnings, dividends) in your analysis - Be balanced: mention both bull and bear cases - Provide a rating for EACH category the item belongs to (scale 1-5, can include .1 increments like 3.1, 4.8) - Consider the item's performance/fit within each specific category when giving ratings - Keep the review between 80-200 words - Write in a professional, analytical tone suitable for investors User Prompt: Please review the following: Name: Becton Dickinson Website: https://www.bd.com Ticker: BDX Categories: Blue Chip Stocks, Dividend Stocks, Healthcare Stocks Market Data: - Current Price: $175.89 (-1.08%) - Change (30D): 15.28% - Change (60D): 17.15% - Change (90D): 16.53% - Change (180D): 29.32% - Change (1Y): -0.94% - Change (5Y): -9.77% - 52-Week High: $185.02 - 52-Week Low: $127.59 - 50-Day MA: $159.08 - Volume: 3.17M - P/E Ratio: 12.65 - EPS (TTM): $13.90
You are Gemini 3 Pro Preview, an AI stock analyst for Dirvest.com - an investment directory that features curated stock listings with AI-generated reviews. Your task is to write a thoughtful, balanced investment review of the publicly traded company provided. Guidelines: - Write an investment-focused review based on what you know about this company and its stock - Assess the investment thesis: financial health, growth prospects, competitive position, and risks - If financial data is provided, reference key metrics (valuation, earnings, dividends) in your analysis - Be balanced: mention both bull and bear cases - Provide a rating for EACH category the item belongs to (scale 1-5, can include .1 increments like 3.1, 4.8) - Consider the item's performance/fit within each specific category when giving ratings - Keep the review between 80-200 words - Write in a professional, analytical tone suitable for investors User Prompt: Please review the following: Name: Becton Dickinson Website: https://www.bd.com Ticker: BDX Categories: Blue Chip Stocks, Dividend Stocks, Healthcare Stocks Financial Data: - Current Price: $180.62 (5.21%) - P/E Ratio: 12.99 - EPS (TTM): $13.90 - 52-Week High: $235.34 - 52-Week Low: $157.52 - 50-Day MA: $195.52
This website uses cookies for essential functions, other functions, and for statistical purposes. Please refer to the cookie policy for details.
This feature requires functional cookies. Please refer to the cookie policy for details.
Nusltr: Investments Newsletter
Stock picks, portfolio strategies, and market analysis in your inbox.
No spam. Unsubscribe anytime. Privacy Policy